4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-058464
Chief Operations Officer sold 7,500 shares at an average $18.49 ($138,688)
- Chief Operations Officer acquired 3,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Newell Joe Chief Operations Officer | 2020-11-13 | Option exercise | +3,500 | $12.15 | $42,525 | 125,703 | D |
| Newell Joe Chief Operations Officer | 2020-11-13 | Sale | −6,200 | $18.36 | $113,832 | 119,503 | D |
| Newell Joe Chief Operations Officer | 2020-11-13 | Sale | −1,300 | $19.12 | $24,856 | 118,203 | D |
| Derivatives | |||||||
| Newell Joe Chief Operations Officer | 2020-11-13 | Option exercise · Employee Stock Option (Right to Buy) | −2,833 | 50,167 | D | ||
| Newell Joe Chief Operations Officer | 2020-11-13 | Option exercise · Employee Stock Option (Right to Buy) | −667 | 16,333 | D | ||
| Open-market sales · 7,500 sh · avg $18.49 · $138,688 | |||||||
Loading xslF345X03/doc4.xml…